Cytokeratin 5/14-positive breast cancer: true basal phenotype confined to BRCA1 tumors

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Modern Pathology

• Publication date

  2005-10-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/modpathol.3800456PMID 15990899
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The relationship between p63 and p53 expression in normal and neoplastic breast tissue.

  2009cited by this paper
• The Catalog of Human Cytokeratins: Patterns of Expression in Normal Epithelia, Tumors and Cultured Cells Review

  2004cited by this paper
• Immunohistochemical and Clinical Characterization of the Basal-Like Subtype of Invasive Breast Carcinoma

  2004cited by this paper
• Use of p63/P504S Monoclonal Antibody Cocktail in Immunohistochemical Staining of Prostate Tissue

  2004cited by this paper
• Different proliferative activity of the glandular and myoepithelial lineages in benign proliferative and early malignant breast diseases

  2004cited by this paper
• Advances in Brief The Prognostic Implication of the Basal-Like ( Cyclin Ehigh / p 27 low / p 53 / Glomeruloid-Microvascular-Proliferation ) Phenotype of BRCA 1-Related Breast Cancer

  2004cited by this paper
• Germline BRCA1 mutations and a basal epithelial phenotype in breast cancer.

  2004cited by this paper
• Basal and luminal breast cancers: basic or luminous? (review).

  2004cited by this paper
• BRCA1 functions as a breast stem cell regulator

  2004cited by this paper
• Hierarchical Clustering Analysis of Tissue Microarray Immunostaining Data Identifies Prognostically Significant Groups of Breast Carcinoma

  2004cited by this paper
• Interlaboratory Comparison of HER-2 Oncogene Amplification as Detected by Chromogenic and Fluorescence in situ Hybridization

  2004cited by this paper
• Cytokeratin 5/6 in normal human breast: lack of evidence for a stem cell phenotype

  2004cited by this paper
• Re: Germline BRCA1 Mutations and a Basal Epithelial Phenotype in Breast Cancer

  2004cited by this paper
• The Prognostic Implication of the Basal-Like (Cyclin Ehigh/p27low/p53+/Glomeruloid-Microvascular-Proliferation+) Phenotype of BRCA1-Related Breast Cancer

  2004cited by this paper
• Expression of luminal and basal cytokeratins in human breast carcinoma

  2004cited by this paper
• Characterization of a novel cell line established from a patient with Herceptin-resistant breast cancer.

  2004cited by this paper
• Evidence of progenitor cells of glandular and myoepithelial cell lineages in the human adult female breast epithelium: a new progenitor (adult stem) cell concept

  2003cited by this paper
• Repeated observation of breast tumor subtypes in independent gene expression data sets

  2003cited by this paper
• Quantitative association between HER-2/neu and steroid hormone receptors in hormone receptor-positive primary breast cancer.

  2003cited by this paper
• Distribution of p63, cytokeratins 5/6 and cytokeratin 14 in 51 normal and 400 neoplastic human tissue samples using TARP-4 multi-tumor tissue microarray

  2003cited by this paper
• Breast cell invasive potential relates to the myoepithelial phenotype

  2003cited by this paper
• Cytogenetic Alterations and Cytokeratin Expression Patterns in Breast Cancer: Integrating a New Model of Breast Differentiation into Cytogenetic Pathways of Breast Carcinogenesis

  2002cited by this paper
• Common Adult Stem Cells in the Human Breast Give Rise to Glandular and Myoepithelial Cell Lineages: A New Cell Biological Concept

  2002cited by this paper
• Differential expression of p63 isoforms in normal tissues and neoplastic cells

  2002cited by this paper
• Keratin expression in human tissues and neoplasms

  2002cited by this paper
• Usual ductal hyperplasia of the breast is a committed stem (progenitor) cell lesion distinct from atypical ductal hyperplasia and ductal carcinoma in situ

  2002cited by this paper
• P63 expression in normal, hyperplastic and malignant breast tissues

  2002cited by this paper
• Family history of breast and ovarian cancers and BRCA1 and BRCA2 mutations in a population-based series of early-onset breast cancer.

  2001cited by this paper
• p63, a p53 Homologue, Is a Selective Nuclear Marker of Myoepithelial Cells of the Human Breast

  2001cited by this paper
• Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

  2001cited by this paper
• Molecular portraits of human breast tumours

  2000cited by this paper
• Cytokeratin 5/6 immunohistochemistry assists the differential diagnosis of atypical proliferations of the breast

  2000cited by this paper
• Biological and prognostic significance of stratified epithelial cytokeratins in infiltrating ductal breast carcinomas

  1998cited by this paper
• Cytokeratins as markers of differentiation in the diagnosis of epithelial tumors.

  1998cited by this paper
• Basal cell-specific and hyperproliferation-related keratins in human breast cancer.

  1991cited by this paper
• NCL‐5D3: A new monoclonal antibody recognizing low molecular weight cytokeratins effective for immunohistochemistry using fixed paraffin‐embedded tissue

  1987cited by this paper
• The catalog of human cytokeratins: patterns of expression in normal epithelia, tumors and cultured cells.

  1982cited by this paper

• EZH2 directs HER2+ breast cancer progression through the modulation of epithelial plasticity.

  2026cites this paper
• Triple-Negative Breast Cancer Progression and Drug Resistance in the Context of Epithelial–Mesenchymal Transition

  2025cites this paper
• Anti-cancer drug sensitivity testing and preclinical evaluation of the anti-cancer potential of WEE1 inhibitor in triple-negative breast cancer patient-derived organoids and xenograft models

  2025cites this paper
• Unveiling the relationship between WWOX and BRCA1 in mammary tumorigenicity and in DNA repair pathway selection

  2024cites this paper
• Navigating the Intricacies of Tumor Heterogeneity: An Insight into Potential Prognostic Breast Cancer Biomarkers

  2024cites this paper
• Cell-targeting Nanomedicine for Bladder Cancer: A Cellular Bioengineering Approach for Precise Drug Delivery

  2024cites this paper
• Cytokeratin 15 is a novel and independent predictor of poor outcome in luminal B HER2-negative breast carcinomas.

  2024cites this paper
• COMPUTATIONAL ANALYSIS OF TRANSCRIPTION FACTORS AS CANCER DRUG TARGETS WITH POTENTIAL INHIBITORS FROM THE NPACT DATABASE

  2023cites this paper
• Harnessing Epigenetics for Breast Cancer Therapy: The Role of DNA Methylation, Histone Modifications, and MicroRNA

  2023cites this paper
• Network Analysis Identifies Potential Small-Molecule Drugs Sensitizing Triple-Negative Breast Cancer to Tamoxifen: Small-Molecule Drugs Re-sensitizing TNBC to Tamoxifen

  2022cites this paper
• Epitheliosis is a histopathological finding associated with malignancy and poor prognosis in dogs with mammary tumors

  2022cites this paper
• Co-Relation of Hormonal Profile and BRCA1 in Sporadic Breast Carcinoma: A Single Institutional Experience of 303 Patients

  2022cites this paper
• Transcript levels of keratin 1/5/6/14/15/16/17 as potential prognostic indicators in melanoma patients

  2021cites this paper
• The Unique Genetic and Histological Characteristics of DMBA-Induced Mammary Tumors in an Organoid-Based Carcinogenesis Model

  2021cites this paper
• Novel Insight of Cytokeratin 14 as a Biomarker in Diagnosing Bladder Cancer

  2021cites this paper
• Cytokeratin 5 and cytokeratin 6 expressions are unconnected in normal and cancerous tissues and have separate diagnostic implications

  2021cites this paper
• Comprehensive Analysis of The Expression and Prognosis For KRTs in LUSC Based on Bioinformatics Analysis

  2021cites this paper
• Insights Into the Impacts of BRCA Mutations on Clinicopathology and Management of Early-Onset Triple-Negative Breast Cancer

  2021cites this paper
• Cancer in General

  2021cites this paper
• Transcript levels of keratin 1/5/6/14/15/16/17 as potential prognostic indicators in melanoma patients

  2021cites this paper
• Germline mutations of multiple breast cancer-related genes are differentially associated with triple-negative breast cancers and prognostic factors

  2020cites this paper
• Double-positive in triple-negative? How significant is basal cytokeratin expression in breast cancer?

  2020cites this paper
• Myxovirus resistance 1 (MX1) is an independent predictor of poor outcome in invasive breast cancer

  2020cites this paper
• Assessment of Cytokeratin Expression in Carcinoma Breast

  2020cites this paper
• Triple-Negative Breast Cancer Comparison With Canine Mammary Tumors From Light Microscopy to Molecular Pathology

  2020cites this paper
• Intermediate Filaments as Effectors of Cancer Development and Metastasis: A Focus on Keratins, Vimentin, and Nestin

  2019cites this paper
• The prognostic significance of wild-type isocitrate dehydrogenase 2 (IDH2) in breast cancer

  2019cites this paper
• Molecular Classification and Prognostic Signatures of Breast Tumors

  2019cites this paper
• BRCA1 mutations attenuate super-enhancer function and chromatin looping in haploinsufficient human breast epithelial cells

  2019cites this paper
• Clinicopathological and prognostic correlations of HER3 expression and its degradation regulators, NEDD4–1 and NRDP1, in primary breast cancer

  2018cites this paper
• Implications of nestin in breast cancer pathogenesis (Review).

  2018cites this paper
• Regulation of epithelial to mesenchymal transition by BRCA1 in breast cancer.

  2018cites this paper
• PTEN PDZ-binding domain suppresses mammary carcinogenesis in the MMTV-PyMT breast cancer model.

  2018cites this paper
• BRCA1-Dependent Transcriptional Regulation: Implication in Tissue-Specific Tumor Suppression

  2018cites this paper
• Practical consensus recommendations on management of triple-negative metastatic breast cancer

  2018cites this paper
• Triple-Negative Breast Cancer: A Comprehensive Study of Clinical, Histomorphological, and Immunohistochemical Features in Indian Patients

  2017cites this paper
• Managing BRCA Mutation Carriers

  2017cites this paper
• Triple negative breast cancer at the Jos University Teaching Hospital

  2017cites this paper
• Pathology of BRCA Tumors

  2017cites this paper
• Expression of calretinin in high-grade hormone receptor-negative invasive breast carcinomas: correlation with histological and molecular subtypes

  2017cites this paper
• Integrated molecular pathway analysis informs a synergistic combination therapy targeting PTEN/PI3K and EGFR pathways for basal-like breast cancer

  2016cites this paper
• Subclassification of the molecular types of breast cancer based on the expression of immunohistochemical markers and evolution.

  2016cites this paper
• Identifying gaps and relative opportunities for discovering membrane proteomic biomarkers of triple-negative breast cancer as a translational priority

  2016cites this paper
• Identification, expansion and characterization of cancer cells with stem cell properties from head and neck squamous cell carcinomas.

  2016cites this paper
• The Role of Immunological Receptors CD74 and CD44 in Association with the Macrophage Migration Inhibitory Factor (MIF) on Human Breast Cancer Derived Cells

  2016cites this paper
• EXPRESSION OF CK5 BASAL CYTOKERATIN DURING METASTATIC DEVELOPMENT OF BREAST CARCINOMA

  2016influential citation
• Differential expression of cellular senescence markers in the assessment of breast cancer development

  2016cites this paper
• Prevalence of Basal-like Breast Cancer among Indigenous Black Zambians at the University Teaching Hospital, Lusaka, Zambia

  2016cites this paper
• Subclasificación de los tipos moleculares de cáncer de mama de acuerdo a la expresión de marcadores inmunohistoquímicos y evolución

  2016influential citation
• Clinical performance of diagnostic, prognostic and predictive immunohistochemical biomarkers for hormone receptor-negative breast cancer

  2015cites this paper
• Fine-Needle Aspirate CYFRA 21-1, an Innovative New Marker for Diagnosis of Axillary Lymph Node Metastasis in Breast Cancer Patients

  2015cites this paper
• Carcinome sécrétant mammaire : un spectre histopathologique et génomique caractérisé par un gène de fusion récurrent ETV6-NTRK3. Analyse clinique, morphologique, immunohistochimique, cytogénétique et moléculaire d’une série de 12 cas de carcinome sécrétant mammaire et revue de la littérature

  2015influential citation
• Heat Shock Proteins in Triple-Negative Breast Cancer (TNBC) Treatment

  2015cites this paper
• Mucins and Cytokeratins as Serum Tumor Markers in Breast Cancer.

  2015cites this paper
• BRCA‐mutated Invasive Breast Carcinomas: Immunohistochemical Analysis of Insulin‐like Growth Factor II mRNA‐binding Protein (IMP3), Cytokeratin 8/18, and Cytokeratin 14

  2015cites this paper
• Heat Shock Protein-Based Therapies

  2015influential citation
• Trp63 is regulated by STAT5 in mammary tissue and subject to differentiation in cancer.

  2014cites this paper
• Quantifizierung von zirkulierenden mikroRNAs im Blut von Mammakarzinom-Patientinnen und ihre Evaluierung als neuer Blut-basierter Tumormarker

  2014cites this paper
• Refined histopathological predictors of BRCA1 and BRCA2mutation status: a large-scale analysis of breast cancer characteristics from the BCAC, CIMBA, and ENIGMA consortia

  2014cites this paper
• BRCA 1/2-Mutation Related and Sporadic Breast and Ovarian Cancers: More Alike than Different

  2014cites this paper
• Applications of Immunohistochemistry in Distinguishing Breast Cancer and Proliferative Lesions

  2014cites this paper
• Comedo-DCIS is a precursor lesion for basal-like breast carcinoma: identification of a novel p63/Her2/neu expressing subgroup

  2013cites this paper
• Cancer of the Breast and Female Reproductive Tract

  2013cites this paper
• Breast cancer precursors: diagnostic issues and current understanding on their pathogenesis

  2013cites this paper
• Understanding Triple-Negative Breast Cancer

  2013cites this paper
• A survey of immunohistochemical biomarkers for basal-like breast cancer against a gene expression profile gold standard

  2013cites this paper
• Breast Cancer Metastasis and Drug Resistance

  2013cites this paper
• Basal/HER2 breast carcinomas

  2013cites this paper
• Clinical application of the one-step nucleic acid amplification method to detect sentinel lymph node metastasis in breast cancer

  2013cites this paper
• Biology and Treatment of Basal-Like Breast Cancer

  2013cites this paper
• Transcription factors link mouse WAP‐T mammary tumors with human breast cancer

  2013cites this paper
• -Till min kära familj

  2012influential citation
• Insights into the targeted elimination of BRCA1‐defective cancer stem cells

  2012cites this paper
• A Case of a Secretory Carcinoma of the Breast: Radio-Pathological Correlation

  2012cites this paper
• Prevalence of BRCA mutations in an unselected population of triple‐negative breast cancer

  2012cites this paper
• Pathologic Features and Immunophenotype of Estrogen Receptor–positive Breast Cancers in BRCA1 Mutation Carriers

  2012cites this paper
• Inference of the Basal Epithelial Phenotype in Breast Carcinoma from Differential Marker Expression, Using Tissue Microarrays in Triple Negative Breast Cancer and Women Younger than 35

  2012cites this paper
• ROLE OF RECEPTORS IN BREAST CANCER

  2012cites this paper
• Morphological and immunohistochemical characteristics of triple negative and basal breast carcinoma

  2012cites this paper
• Triple-Negative and Basal-like Carcinoma

  2012cites this paper
• Importance of HLA-G expression and tumor infiltrating lymphocytes in molecular subtypes of breast cancer.

  2012cites this paper
• Ekspresija citokeratina 5/6 i citokeratina 17 u invazivnom karcinomu dojke

  2012cites this paper
• Dissecting the heterogeneity of triple-negative breast cancer.

  2012cites this paper
• Electrospun fibrous scaffolds promote breast cancer cell alignment and epithelial-mesenchymal transition.

  2012cites this paper
• Immunohistochemical characterization of molecular subtypes of invasive breast cancer: a study from North India

  2012cites this paper
• [Expression of cytokeratins 5/6 and cytokeratin 17 in invasive breast carcinoma].

  2012cites this paper
• BRCA1 and GATA3 corepress FOXC1 to inhibit the pathogenesis of basal-like breast cancers

  2012cites this paper
• The DeltaNp63 proteins are key allies of BRCA1 in the prevention of basal-like breast cancer.

  2011cites this paper
• Triple-Negative Breast Cancer: Adjuvant Therapeutic Options

  2011cites this paper
• CK8/18 expression, the basal phenotype, and family history in identifying BRCA1‐associated breast cancer in the Ontario site of the Breast Cancer Family Registry

  2011cites this paper
• A novel myoepithelial cell marker in canine mammary tissue.

  2011cites this paper
• Acetic acid treatment for wrinkle‐free oral mucosal epithelia in paraffin section preparation

  2011cites this paper
• Basal Phenotype Breast Cancer: Implications for Treatment and Prognosis

  2011cites this paper
• Basal-Like Phenotype in a Breast Carcinoma Case Series from Sudan: Prevalence and Clinical/Pathological Correlations

  2011influential citation
• Management Options in Triple-Negative Breast Cancer

  2011cites this paper
• Phenotype-Genotype Correlation in Familial Breast Cancer

  2011cites this paper
• Tracking mammary epithelial cell lineage and cell divisions in the normal mammary gland and mammary neoplasia using transgenic mice

  2011cites this paper
• Nuclear and cytoplasmic expressions of ERβ1 and ERβ2 are predictive of response to therapy and alters prognosis in familial breast cancers

  2011cites this paper
• Stromal Modulation of Radiation Carcinogenesis in Breast Cancer

  2011cites this paper
• Signalling pathways in basal-like breast carcinomas: a clue on pathogenesis and therapeutical targets.

  2011cites this paper